FDA.reportPublic FDA data

Emflaza 36 MG Oral Tablet

RxCUI
1870960
RxNorm name
Emflaza 36 MG Oral Tablet
Display name
Emflaza 36 MG Oral Tablet
Full name
Emflaza 36 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
31b347d2-f156-4055-9d8f-7cf0df420296Emflaza 36 MG Oral Tablet [PSN] · deflazacort 36 MG Oral Tablet [Emflaza] [SBD] · Emflaza 36 MG Oral Tablet [SY]321These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 201720251113